. 2017 Mar;145(3):271–293. doi: 10.4103/ijmr.IJMR_177_16
Copyright: © 2017 Indian Journal of Medical Research
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Table III.
Grouping of anti-tuberculosis drugs
